Inari Medical Inc. (NARI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Inari Medical, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Inari Medical, Inc. Investors: Reach Out to Schall Law Firm for Advocacy and Support Amid Losses
LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - NARI
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
The Schall Law Firm Urges Investors with Losses in Inari Medical, Inc. to Reach Out Before the Deadline
LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
NARI LAWSUIT ALERT: Levi & Korsinsky Notifies Inari Medical, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Investors in Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Contact Hagens Berman by July 12, 2024 Deadline to Join Class Action Against Inari Medical, Inc. (NARI)
SAN FRANCISCO, CA / ACCESSWIRE / June 4, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 24, 2022 - Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: [email protected] 844-916-0895 Inari Medical, Inc. (NARI) Class Action: Inari Medical, a medical device manufacturer, is bracing for a protracted investigation by the Department of Justice (DOJ) centering on allegations of illegal kickbacks to healthcare professionals.
The Schall Law Firm Advocates for Investors in Inari Medical, Inc. Suffering Losses to Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and February 28, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 12, 2024.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 12, 2024 in Inari Medical, Inc. Lawsuit - NARI
NEW YORK, NY / ACCESSWIRE / June 4, 2024 / If you suffered a loss on your Inari Medical, Inc. (NASDAQ:NARI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NARI Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Inari Medical, Inc. Investors with Losses to Contact the Firm
RADNOR, PA / ACCESSWIRE / June 4, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Inari Medical, Inc. ("Inari Medical") (NASDAQ:NARI) on behalf of investors who purchased or acquired Inari Medical common stock between February 24, 2022 through February 28, 2024, inclusive (the "Class Period"). The action charges Inari Medical with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.
